Cargando…
Decursin and Doxorubicin Are in Synergy for the Induction of Apoptosis via STAT3 and/or mTOR Pathways in Human Multiple Myeloma Cells
Background. Combination cancer therapy is one of the attractive approaches to overcome drug resistance of cancer cells. In the present study, we investigated the synergistic effect of decursin from Angelica gigas and doxorubicin on the induction of apoptosis in three human multiple myeloma cells. Me...
Autores principales: | Jang, Jinsil, Jeong, Soo-Jin, Kwon, Hee-Young, Jung, Ji Hoon, Sohn, Eun Jung, Lee, Hyo-Jung, Kim, Ji-Hyun, Kim, Sun-Hee, Kim, Jin Hyoung, Kim, Sung-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684033/ https://www.ncbi.nlm.nih.gov/pubmed/23818927 http://dx.doi.org/10.1155/2013/506324 |
Ejemplares similares
-
Inhibition of STAT3 signaling and induction of SHP1 mediate antiangiogenic and antitumor activities of ergosterol peroxide in U266 multiple myeloma cells
por: Rhee, Yun-Hee, et al.
Publicado: (2012) -
Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells
por: Jiang, Cheng, et al.
Publicado: (2007) -
Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation
por: Kim, Jeong Hun, et al.
Publicado: (2009) -
mTOR-Mediated Antioxidant Activation in Solid Tumor Radioresistance
por: Woo, Yunseo, et al.
Publicado: (2019) -
Decursin inhibits tumor progression in head and neck squamous cell carcinoma by downregulating CXCR7 expression in vitro
por: Joo, Mina, et al.
Publicado: (2022)